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Abstract
We assessed the rates, trends, and factors associated with venous thromboembolism (VTE) 
diagnosis among hospitalizations of adults ≥60 years of age during the period 2001 to 2010. Data 
from the National Hospital Discharge Survey were used for this study. During the period 2001 to 
2010, the estimated annual number of hospitalizations in which a VTE diagnosis was recorded, 
among adults ≥60 years of age, ranged from approximately 2 70 000 in 2001 to 4 23 000 in 2010. 
The rate of such hospitalizations per 1 00 000 US population ≥60 years of age ranged from 581 in 
2001 to 739 in 2010. During the period 2001 to 2004, there was a significant increasing trend in 
the rate of hospitalizations with VTE among women ≥60 years of age. The factors positively 
associated with an increased risk of VTE diagnosis were female sex, summer and autumn seasons 
(compared with spring), venous catheterization, cancer, and greater length of hospital stay.
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Introduction
Venous thromboembolism (VTE), which consists of deep vein thrombosis (DVT) or 
pulmonary embolism (PE) or both, is an important public health concern.1,2 VTE is much 
more likely to affect people who are older.3–6 A 1999 population-based study among 
residents of Worchester, Massachusetts found that the annual VTE incidence was 57, 138, 
348, and 600 per 1 00 000 population among those <55, 55 to 64, 65 to74, and ≥75 years of 
age, respectively.4 A study among residents of Olmsted County in Minnesota found that 
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between 1986 and 1990, the annual incidence rates of VTE among persons in age groups 
that were <60 years of age ranged between 0 and 132 per 1 00 000 population for women 
and 0 and 149 for men; the rates among persons in age groups that were ≥60 years age 
ranged from 169 to 829 per 1 00 000 population for women and 163 to783 for men.3 
Hospitalization is also a risk factor for VTE.4,7,8 A substantial number of patients develop 
VTE during their hospitalization stay.9,10 In addition, a large proportion of VTE that occurs 
in the outpatient settings is associated with recent hospitalization.4,9–11 Hospitalization may 
increase the risk of VTE through individual and synergistic effects of illness, injury, 
immobility, and surgery.1,10
Reduction in VTE events among hospitalized older adults will improve patient outcomes. In 
this context, better epidemiologic understanding of VTE among hospitalized older adults, 
including identification of the rates of occurrence and demographic and comorbid risk 
factors, can help in the development and the assessment of effective prevention strategies. 
Using a large national sample, this study estimated the number and rates (per 1 00 000 
population) of hospitalizations of older adults in which there was a recorded discharge 
diagnosis of VTE (as defined in this study), assessed trends in the rates for the period 2001 
to 2010, and identified characteristics and comorbidities associated with an increased 
likelihood of a VTE diagnosis.
Methods
Data were used from the 2001 to 2010 National Hospital Discharge Survey (NHDS), which 
was conducted annually until 2010 by the National Center for Health Statistics (NCHS) of 
the Centers for Disease Control and Prevention. A multistage complex sampling design was 
used to select a sample of hospitals throughout the United States that were short-stay 
hospitals (average length of patient stay <30 days), had ≥6 inpatient beds, and were not 
federal, military, or Veterans Administration hospitals. Data collected from sampled 
discharges from each hospital included patient age, sex, length of hospital stay, month of 
hospital discharge, and disposition of the patient as well as listed diagnoses and procedures 
that were indicated using International Classification of Disease, Ninth Revision, Clinical 
Modification (ICD-9-CM) codes. The 2001 to 2009 NHDS recorded up to 7 diagnoses and 
up to 4 procedures; the 2010 NHDS recorded up to 15 listed diagnoses and up to 8 
procedures. More information about the NHDS can be found at the following Web site: 
http://www.cdc.gov/nchs/nhds.htm.
Hospitalizations in which a discharge diagnosis of VTE was recorded were defined in this 
study as those having 1 or more of selected ICD-9-CM codes indicating a diagnosis of DVT 
or PE or both. Because there were changes in ICD-9-CM codes for DVT during the period 
2001 to 2010, there were some differences in the ICD-9-CM codes used to identify DVT 
diagnoses as per our study definition during the selected time periods in this study. The 
ICD-9-CM codes used for different time periods are presented in Table 1. We assessed the 
associations between VTE diagnosis and selected patient- and hospitalization-related 
characteristics, including age group, sex, length of hospital stay, season of hospitalization 
(based on the discharge month), venous catheterization, and the medical conditions of 
cancer (all types, including those indicated to be in remission), heart failure, stroke, chronic 
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obstructive pulmonary disease, diabetes, hypothyroidism, autoimmune and/or inflammatory 
diseases (inflammatory bowel disease, systemic lupus erythematosus, rheumatoid arthritis, 
or inflammatory polyarthropathy, or any combination of these), infection (selected 
categories of infectious and paracytic diseases), injury, paralysis of limb, and varicose veins. 
The reasons for assessing these characteristics included that they had been reported 
previously as possibly being associated with VTE12–16; information on these was available 
in the data source, and there were ≥30 observations of hospitalizations with the 
characteristic and VTE diagnosis. Diagnoses of the selected medical conditions and venous 
catheterization were identified using the ICD-9-CM coded information (the ICD-9-CM 
codes are presented in Appendix A).
Analysis
The analysis was weighted to represent all hospitalizations of patients ≥60 years of age 
occurring nationally during the period 2001 to 2010 in the types of hospitals included in the 
NHDS survey. The estimated annual number of hospitalizations with a diagnosis of VTE 
was applied to the US Bureau of Census’ mid-year population estimates to derive the annual 
rates of such hospitalizations per 1 00 000 population ≥60 years of age. Information about 
the methodology used by the Census Bureau in developing population estimates can be 
found at the following Web site: http://www.census.gov/popest/index.html. The year-wise 
trend in the rate of hospitalizations in which a VTE diagnosis was recorded was assessed by 
linear regression modeling using the estimated annual rates as the outcome variable and year 
as the predictor variable. Because the set of ICD-9-CM codes used to identify DVT 
diagnosis in this study changed in 2005 and 2010, the year-wise trends in the rate of 
hospitalizations in which a VTE diagnosis was recorded was also assessed separately for the 
time periods 2001 to 2004 and 2005 to 2009.
The associations between hospitalizations in which a VTE diagnosis was recorded and 
selected patient- and hospitalization-related characteristics were assessed using combined 
data for the years 2001 to 2010. The frequency of hospitalizations with a recorded VTE 
diagnosis (per 1000 hospitalizations) was estimated by these characteristics, and the 
statistical significance of differences was assessed by the chi-square test. Characteristics 
associated with VTE, chi-square P < .05, were entered in a multiple logistic regression 
model to assess independent association with VTE. SAS software (release 9.3, SAS 
Institute, Inc., Cary, NC, USA) was used for the yearly trend analysis. The remainder of the 
analysis was conducted using SAS-callable SUDAAN (release 10.0.1, Research Triangle 
Institute, Research Triangle Park, NC, USA). The analysis was adjusted for the complex 
survey design when estimating variances using design variables accessed through the 
NCHS’s Research Data Centers.
Results
The study sample had an unweighted total of 1.137 million observations of hospitalizations 
among patients ≥60 years of age. Of these, 25 753 had a VTE diagnosis recorded. The 
estimates presented hereafter are nationally weighted estimates. The estimated yearly 
number of hospitalizations in which a VTE diagnosis was recorded ranged from 
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approximately 2 70 000 (95% confidence interval [CI] 2 39 000–3 00 000) in 2001 to 4 23 
000 (95%CI 3 24 000–5 22 000) in 2010. The rate of hospitalizations in which a VTE 
diagnosis was recorded per 1 00 000 population of all adults ≥60 years of age increased 
from 581 (95% CI 515–646) in 2001 to 739 (95% CI 567–912) in 2010 (Figure 1). For men 
≥60 years age, this rate increased from 534 (95%CI 453–616) in 2001 to 822 (95%CI 603–
1041) in 2010; for women, the increase was from 615 (95%CI 547–684) in 2001 to 673 
(95% CI 520–826) in 2010.
During the period 2001 to 2010, there was a significant increase in the rate of 
hospitalizations in which a VTE discharge diagnosis was recorded per 1 00 000 for men ≥60 
years of age (P = .010) and a close to significant increase in all adults ≥60 years of age (P = .
064; Table 2). During the period 2001 to 2004, there was a significant increase in the rate for 
all adults ≥60 years age (P = .035) and women ≥60 years age (P = .010). There was no 
significant increase in the rate during the period 2005 to 2009.
The disposition in 6.6% of the hospitalizations in which a VTE diagnosis was recorded 
among patients ≥60 years age was that the patient died. The case fatality rate among 
hospitalizations with a PE (with or without a DVT) diagnosis was 9.5%; among 
hospitalizations with a DVT (but not a PE) diagnosis, it was 4.4%.
In bivariate analyses, the frequency of VTE diagnosis varied significantly (chi-square P < .
05) by a number of the factors assessed (Table 3). Factors associated with an increased 
frequency of VTE diagnosis included female sex, venous catheterization, diagnosis of 
cancer, season (summer and autumn), and greater length of hospital stay. In multivariable 
analysis, factors positively associated with a VTE diagnosis were female sex (odds ratio 
[OR] 1.08, 95% CI 1.02–1.14), increased length of hospital stay (OR 2.42, 95% CI 2.23–
2.62 for 4 to 6 days of hospital stay and OR 3.40, 95% CI 3.12–3.70 for ≥7 days), date of 
discharge during summer and autumn seasons (compared to spring; OR 1.08, 95% CI 1.01–
1.15 and OR 1.13, 95% CI 1.05–1.21, respectively), having venous catheterization (OR 
1.43, 95% CI 1.28–1.59), and diagnosis of cancer (OR 1.64, 95% CI 1.51–1.79).
Discussion
It is important to assess hospitalizations with a VTE diagnosis and associated factors among 
older adults, because older adults are at higher risk of VTE occurrence in general. Research 
has well established that VTE rates are substantially higher among this group.1–4 Our study 
findings indicated that a substantial number of hospitalizations with a recorded diagnosis of 
VTE, as per our study definition, occurred among older adults. Rates of hospitalizations in 
which a VTE diagnosis was recorded increased during the period 2001 to 2004. In addition, 
risk factors associated with a VTE diagnosis among hospitalized older adults may include 
venous catheterization and selected comorbidities or conditions.
In 2010, there were an estimated 4 23 000 hospitalizations of adults ≥60 years of age with a 
recorded diagnosis of VTE, leading to a rate of 739 per 1 00 000 population in this age 
group. The findings of this study indicated that the rate of hospitalizations in which a VTE 
diagnosis was recorded increased during the period 2001 to 2010 among men ≥60 years of 
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age. When trends in the rates were assessed separately for the periods 2001 to 2004 and 
2005 to 2009 (because of the use of common sets of ICD-9-CM codes in this study to 
identify DVT during these periods), we found an increase in the rate during the period 2001 
to 2004 among women ≥60 years of age, with the rates being comparatively stable for both 
men and women during the period 2005 to 2009.
Several factors might explain the increase in the rate of hospitalizations in which a VTE 
diagnosis was recorded during the period 2001 to 2004. One reason may be newer 
diagnostic technology, the availability, and the use of which has increased during this 
period.17–19 For example, research focusing on emergency departments during the period 
1996 to 2007 reported a 5 times increase in the use of computed tomography (CT) scans 
among patients with chest pain and shortness of breath, both common symptoms of PE.17 
Studies have also reported increased CT use among inpatients with these kinds of 
symptoms.18,19 Other factors that possibly could have contributed to an increased rate of 
VTE diagnosis included older average age of the general US population; possible changes in 
the prevalence of VTE risk factors, such as obesity; increased awareness of VTE among 
patients, providers, and the public in general; and better documentation of VTE.
A substantial percentage of hospitalized patients with a VTE diagnosis died during 
hospitalization. It is not known what percentage of the deaths among patients ≥60 years of 
age was attributable to a PE event. The PE-related case fatality rate among patients ≥60 
years of age found in this study (9.5%) was higher than the rate reported previously among 
all non-newborn patients (7.1% during the period 2007–2008).20 Research assessing case-
fatality rates among hospitalized patients have found that case-fatality rates among patients 
with PE increase with advancing age.21
In the current study, a number of the characteristics or comorbidities assessed were 
associated with an increased likelihood of a VTE diagnosis among hospitalizations of older 
adults. Cancer is an important risk factor for VTE.10,14 In a study using a patient 
information database that included patients from 374 hospitals in the United States, the 
relative risks of VTE among patients aged 18 to 49, 50 to 64, and ≥65 years with cancer 
were 2.17, 3.64, and 4.62, respectively, compared to patients aged 18 to 49 years without 
cancer.22 In another study assessing VTE risk among hospitalized patients of all ages with 
cancer, the investigators found that an increased risk of VTE was associated with almost all 
of the 19 different types of cancer studied; however, the magnitude of the increased risk 
varied by the type of cancer.23 In the current study, hospitalizations of older adult patients 
with cancer had a substantially increased likelihood of having a recorded VTE diagnosis 
compared with hospitalizations of older adult patients without cancer. Our finding of the 
greater risk of VTE associated with venous catheterization is consistent with previous 
reports.10,24
Other studies have reported a possible seasonal variation in VTE occurrence, with increased 
incidence during winter.25,26 Hypotheses on why VTE risk may be higher during winter 
include that the risk is affected by seasonal variation in biochemical markers, including 
coagulation-related markers (eg, fibrinogen).25 The findings of the current study did not 
indicate VTE risk to be higher during the winter with the OR being slightly higher among 
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discharges during autumn and summer, compared to spring. Previous research has also 
indicated that increased length of hospital stay might be associated with a higher VTE 
risk.11,21 However, VTE occurrence during hospitalization can itself increase the length of 
stay, and our finding could be—at least partially—because of this. In addition, it might be 
that the observed association is partly because longer length of stay increases the time for 
diagnosis of VTE. Although age group was not significantly associated with VTE diagnosis 
in this study, other studies have reported increased rates and incidences of VTE by 
increasing age categories among older adults.3,5,8
We do not know why a number of factors, such as heart failure, stroke, and injury, that have 
been previously reported to be risk factors for VTE were not associated with VTE in this 
study and, in fact, appeared to be negatively associated with (ie, have a protective effect 
against) VTE. Several previous studies using hospital discharge data that included broader 
adult age groups have reported increased risks of VTE associated with several conditions 
including HIV infection, inflammatory bowel disease, hypothyroidism, diabetes mellitus, 
rheumatoid arthritis, nephrotic syndrome, chronic obstructive pulmonary disease, and heart 
failure; however, a number of studies also found that the risk of VTE associated with the 
respective comorbiditiy assessed tended to be lower among older age groups compared to 
younger adults (14, C–J).14,27–34 Our findings do not necessarily mean that these factors are 
not associated with an increased risk of VTE among hospitalized older adults. Our 
conjectures on possible reasons include that because of the perceived VTE risk, patients 
with these risk factors may have been more likely to receive VTE prevention measures, and 
this, at least partially, could have affected our findings. It may also be possible that these 
risk factors have different effects on VTE risk (for example they may increase VTE risk to a 
lesser extent) among the cohort older adults assessed in this study than groups assessed in 
some other studies.
Limitations of this study included that ICD-9-CM coded diagnoses in discharge survey data 
are not always accurate in identifying patients with VTE; however, research has indicated 
that the positive predictive values associated with many of the VTE-related ICD-9-CM 
codes used in this study may be between 75% and 95%.35 It is likely that for a large 
proportion of the hospitalizations in which a VTE diagnosis was recorded, the VTE occurred 
prior to hospitalization.9,10 However, because of unavailability of adequate information, this 
study did not distinguish these separately. Because of the unavailability of information, this 
study could not assess other possible risk factors for VTE, such as smoking or recent 
hospitalization, or the risk of VTE associated with specific types of venous catheterization.
The administration of VTE prophylaxis during or before hospitalization would have reduced 
the risk of VTE and, thus, could have affected the findings of this study; however, because 
we did not have information on whether or not the patients received VTE prophylaxis, we 
do not know to what extent this may have occurred. It is possible that in recent years, more 
patients with VTE were treated in the outpatient setting than before, which could have 
affected our findings related to trends in hospitalizations with a VTE diagnosis. However, 
we do not know to what extent this may have occurred. In addition, findings related to the 
trends in the rates of hospitalizations during the period 2001 to 2010 should be interpreted in 
the context of the changes in the ICD-9-CM codes used to define VTE over the study period. 
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We do not know to what extent the changes ICD-9-CM codes we used affected the findings 
of lower point estimates of rates of VTE diagnosis in 2005 (the beginning of a period with 
new codes) compared to 2004 (the end of the period with older codes). However, there were 
no changes in the codes used for the years 2001 to 2004 and 2005 to 2009 time periods.
Many episodes of VTE could possibly be prevented through the use of pharmacological 
prophylaxis and other strategies.36,37 Possible adverse events from anticoagulants include 
bleeding, the risk of which has been reported to be higher among older adults compared with 
those who are younger.38,39 Such bleeding complications could include serious events such 
as hemorrhagic stroke and other life-threatening events. Clinical considerations related to 
VTE prophylaxis include the benefits and risks of anticoagulants and other measures. The 
VTE prevention guidelines from professional bodies can help guide VTE prophylaxis 
decisions. Increased knowledge and understanding of VTE occurrence among older adults is 
also needed. In this context, the findings of this study can help to increase awareness of VTE 
and improve understanding of its effects, time trends, and risk factors among hospitalized 
older adults. Improved implementation of VTE prevention strategies as appropriate may 
help to reduce VTE occurrence and improve patient outcomes.
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Appendix A
International Classification of Disease, 9th Revision, Clinical Modification codes used for 
identifying hospitalizations with diagnoses of selected medical conditions (diagnosis codes) 
and venous catheterization (procedure code)
Cancer: 140.xx-208.xx, 209.0x-209.3x
Heart failure: 402.01, 402.11, 402.91, 404.01, 404.03, 404.11, 404.13, 404.91, 404.93, 
428.xx
Stroke: 431, 434.xx, 436
COPD: 491.2x, 492.x, 493.2x, 496
Diabetes: 250.xx
Hypothyroid: 244.x
Autoimmune/inflammatory diseases: 555.x, 556.x, 710.0, 714.xx
Injury: 800.xx-908.xx, 910.xx-959.xx, E800.x-E848.x, E880.x-E929.x, E950.x-E999.x
Infection: 001.xx-139.xx
Paralysis of limb: 342.xx, 344, 344.0x, 344.1, 344.2, 344.3x, 344.5
Varicose vein: 454.x, 456.xx
Venous catheterization: 38.93
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Estimated number of hospitalizations in which a diagnosis of venous thromboembolism 
(VTE) was recorded per 1 00 000 population ≥60 years of age, from 2001 to 2010.
Note: Error bars indicate 95% confidence intervals.
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Table 1
The ICD-9-CM Codes Used As per the Study Definition to Identify Hospitalizations in Which a Deep Vein 
Thrombosis or Pulmonary Embolism Diagnosis or Both, Were Recorded.
Disorder and Time Period ICD-9-CM Codes
DVT
 2001–2004 451.1, 451.11, 451.19, 451.2, 451.81, 451.83, 451.84, 451.89, 451.9, 453.2, 453.8
 2005–2009 451.1, 451.11, 451.19, 451.2, 451.81, 451.83, 451.84, 451.89, 451.9, 453.2, 453.4, 453.40, 453.41, 453.42
 2010 451.11, 451.19, 451.2, 451.81, 451.83, 451.84, 451.89, 451.9, 453.2, 453.40, 453.41, 453.42, 453.82, 453.83, 
453.84, 453.85, 453.86, 453.87, 453.89
PE
 2001–2010 415.11, 415.19
Abbreviations: ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification; DVT, deep vein thrombosis; PE, 
pulmonary embolism.
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Table 2
Year-Wise Trends in the Rate of Hospitalization in Which a Venous Thromboembolism Diagnosis Was 
Recorded per 1 00 000 Population of Adults >60 Years of Age.
Time Period Slope of Regression Line, β (SE) P Value for Trend
2001–2010
 Men 21.8 (6.5) .010
 Women 3.2 (5.9) .598
 All 11.3 (5.2) .064
2001–2004
 Men 35.5 (13.1) .114
 Women 47.8 (4.8) .010
 All 42.1 (8.1) .035
2005–2009
 Men 25.5 (12.9) .143
 Women 19.3 (16.0) .314
 All 22.1 (13.1) .191
Abbreviation: SE, standard error.
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Table 3
Frequency of a Venous Thromboembolism (VTE) Diagnosis Recorded per 1000 Hospitalizations by Selected 
Patient Characteristics and Comorbidities and the Independent Association of These Characteristics With a 
VTE Diagnosis Being Recorded Among Hospitalizations of Adults ≥60 Years of Age, 2001 to 2010.
Characteristic Unweighted Number of Observations VTE per 1000 Hospitalizations (95% CI) Odds Ratio for VTE (95% CI)
Age, years
 60–69 3 37 101 21.1 (19.7–22.4) NA
 70–79 3 92 551 22.0 (20.7–23.2) NA
 80+ 4 07 496 21.5 (20.3–22.8) NA
Men 4 88 925 20.8 (19.7–22.0)a Ref.
Women 6 48 223 22.1 (20.9–23.3) 1.08 (1.02–1.14)
Length of stay, days
 0–3 5 08 468 11.0 (10.3–11.8)a Ref.
 4–6 3 21 547 25.2 (23.9–26.5) 2.42 (2.23–2.62)
 7+ 3 07 133 36.1 (34.0–38.2) 3.40 (3.12–3.70)
Season
 Spring 2 97 955 20.6 (19.5–21.7)a Ref.
 Summer 2 81 224 22.0 (20.5–23.6) 1.08 (1.01–1.15)
 Autumn 2 72 316 23.1 (21.6–24.7) 1.13 (1.05–1.21)
 Winter 2 85 653 20.6 (19.4–21.9) 1.00 (0.93–1.07)
Venous catheter
 No 10 87 774 20.7 (19.7–21.7)a Ref.
 Yes 49 374 41.0 (37.5–44.7) 1.43 (1.28–1.59)
Diagnosis of cancer
 No 10 13 708 19.6 (18.6–20.7)a Ref.
 Yes 1 23 440 38.1 (35.4–40.9) 1.64 (1.51–1.79)
Heart failure
 No 8 94 355 22.4 (21.3–23.5)a Ref.
 Yes 2 42 793 18.3 (17.1–19.6) 0.76 (0.70–0.82)
Stroke
 No 11 02 666 21.8 (20.8–22.9)a Ref.
 Yes 34 482 13.0 (11.0–15.4) 0.52 (0.44–0.61)
COPD
 No 9 13 183 22.3 (21.2–23.3)a Ref.
 Yes 2 23 965 18.5 (17.0–20.0) 0.77 (0.72–0.83)
Diabetes
 No 8 88 718 23.2 (22.1–24.3)a Ref.
 Yes 2 48 430 15.7 (14.7–16.9) 0.71 (0.67–0.76)
Hypothyroid
 No 10 48 648 21.7 (20.7–22.8)a Ref.
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Characteristic Unweighted Number of Observations VTE per 1000 Hospitalizations (95% CI) Odds Ratio for VTE (95% CI)
 Yes 88 500 19.3 (17.6–21.3) 0.94 (0.85–1.05)
Autoimmune/Inflam dsb
 No 11 15 854 21.5 (20.5–22.5) NA
 Yes 21 294 24.0 (20.1–28.6) NA
Injuryc
 No 10 47 884 22.2 (21.2–23.2)a Ref.
 Yes 89 264 14.6 (12.7–16.7) 0.58 (0.52–0.65)
Infectiond
 No 10 06 986 21.3 (20.3–22.3)a Ref.
 Yes 1 30 162 23.5 (21.7–25.4) 0.80 (0.74–0.87)
Paralysis of limb
 No 11 23 422 21.6 (20.6–22.6) NA
 Yes 13 726 19.8 (14.9–26.3) NA
Varicose vein
 No 11 33 810 21.5 (20.5–22.6) NA
 Yes 3338 30.4 (22.1–41.7) NA
Abbreviations: VTE, venous thromboembolism; CI, confidence interval; NA, not applicable (only characteristics univariately associated (chi-
square P < .05 in column 3) with VTE diagnosis were entered in the multivariable model); COPD, chronic obstructive pulmonary disease.
a
Chi-square P < .05.
b
Autoimmune and inflammatory diseases comprised diagnosis of inflammatory bowel disease, systemic lupus erythematosus, rheumatoid arthritis, 
or inflammatory polyarthropathy, or any combination thereof.
c
Injury group comprised trauma and other categories of injury.
d
Infection group comprised selected categories of infectious and parasitic diseases.
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